| Add to balance / Manage account | User: | Log out |
| Prospect News home > News index > List of issuers C > Headlines for CanSino Biologics Inc. > News item |
CanSino Biologics to issue HK$6 billion convertible bonds
By Abigail W. Adams
Portland, Me., April 20 – CanSino Biologics Inc. received regulatory approval from the China Securities Regulatory Commission to issue up to HK$6 billion in convertible bonds, according to a company announcement.
The bonds will be convertible into H shares of the company.
The company will select an appropriate time to proceed with the convertible bonds with approval good for 12 months, according to the release.
CanSino is a Tianjin, China-based vaccine company.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.